Latest news
29-08-2024 - $2 Million for Clinical Trials to Repurpose Metabolic Therapies for Diabetes
Breakthrough T1D is offering funding of up to $2 million through its latest Request for Applications - Clinical Trials Advancing Metabolic Therapies for T1D - to support clinical trials to evaluate repurposed therapies that can improve metabolic outcomes in people with type 1 diabetes (T1D) or clinical research projects to investigate the underlying mechanisms of metabolic dysfunction in T1D to inform future therapy development.
[...]